JPMORGAN CHASE & CO - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 43 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$25,397
-98.2%
27,000
-98.2%
0.00%
Q1 2023$1,381,000
+76156.2%
1,497,000
-24.9%
0.00%
Q4 2022$1,811
-99.9%
1,993,000
+33.3%
0.00%
Q3 2022$1,359,000
-71.1%
1,495,000
-71.3%
0.00%
-100.0%
Q1 2022$4,700,000
+413.7%
5,218,000
+422.8%
0.00%
Q3 2021$915,000998,0000.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Opti Capital Management, LP 42,313,000$37,738,0003.63%
DeepCurrents Investment Group LLC 78,898,000$69,839,0002.79%
STEELHEAD PARTNERS LLC 31,350,000$27,716,0002.38%
Sonora Investment Management Group, LLC 20,200,000$17,734,0001.68%
Penn Mutual Asset Management, LLC 1,256,000$1,103,0001.49%
TENOR CAPITAL MANAGEMENT Co., L.P. 64,271,000$57,050,0001.28%
CAMDEN ASSET MANAGEMENT L P /CA 21,346,000$18,752,0000.58%
AVIVA PLC 60,265,000$52,901,0000.28%
OAKTREE CAPITAL MANAGEMENT LP 24,313,000$21,480,0000.25%
ADVENT CAPITAL MANAGEMENT /DE/ 13,680,000$12,086,0000.21%
View complete list of IONIS PHARMACEUTICALS INC shareholders